Brodersen R, Funding L
Scand J Clin Lab Invest. 1977 May;37(3):257-66. doi: 10.1080/00365517709091491.
Binding of bilirubin to human serum albumin was studied by estimation of the free bilirubin concentration from the rate of oxidation with hydrogen peroxide and peroxidase, and by spectrophotometry: nI = 1, kI = 7 x 10(7) l/mol; nII = 1, kII = 5 x 10)5) l/mol, at pH 7.4, 37 degrees C, ionic strength 0.1. Palmitate or oleate in excess of 4 mol per mol albumin, influences the high-affinity binding of bilirubin as described by an empirical equation. Theoretical consideration of competitive displacement of a biologically active substance, firmly bound in an inactive state to a macromolecular carrier, demonstrates that significant displacement may occur on addition of another ligand with a lower binding constant. Displacement of bilirubin from its high-infinity site by fatty acids and drugs is thermodynamically feasible and probably clinically important.
通过用过氧化氢和过氧化物酶氧化速率估算游离胆红素浓度以及采用分光光度法,研究了胆红素与人血清白蛋白的结合情况:在pH 7.4、37℃、离子强度0.1条件下,nI = 1,kI = 7×10⁷ l/mol;nII = 1,kII = 5×10⁵ l/mol。每摩尔白蛋白中棕榈酸盐或油酸盐超过4摩尔时,会如经验方程所述影响胆红素的高亲和力结合。对一种生物活性物质以无活性状态牢固结合于大分子载体上的竞争性置换进行理论考量表明,添加另一种结合常数较低的配体时可能会发生显著置换。脂肪酸和药物使胆红素从其高亲和力位点发生置换在热力学上是可行的,且可能具有临床重要性。